INO:NASDAQ
Inovio Pharmaceuticals Inc
1,43 $
0,00%
(0,00) 1D
1,40 $
arrow_downward
-1,87% (-0,027)todayPre-market
Closed: 13 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Mkt. cap
267,85 մլն
Avg. vol.
19,34 մլն
Volume
80,21 հզր
52-wk high
2,72 $
52-wk low
0,56 $
EPS
-0,80 $
Beta
1,71
Shares outstanding
187,31 մլն
No. of employees
112
Mkt. cap
267,85 մլն
Avg. vol.
19,34 մլն
Volume
80,21 հզր
52-wk high
2,72 $
52-wk low
0,56 $
EPS
-0,80 $
Beta
1,71
Shares outstanding
187,31 մլն
No. of employees
112
News stories
From web sources and news partners
Yahoo Finance
·
37 րոպե առաջ
Nearly a fifth of the S&P 500 is tied to three men with no clear successors
Kitco
·
58 րոպե առաջ
S&P 500, Nasdaq futures fall ahead of Nvidia earnings, Anthropic IPO
Business Insider
·
3 ժամ առաջ
A veteran strategist sees a split in the stock market leading to a 15% drop in the S&P 500
FXEmpire
·
24 րոպե առաջ
Why The S&P 500 Could Fall 63% – And Still Only Be Fairly Valued
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc